OA12340A - Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. - Google Patents

Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. Download PDF

Info

Publication number
OA12340A
OA12340A OA1200300012A OA1200300012A OA12340A OA 12340 A OA12340 A OA 12340A OA 1200300012 A OA1200300012 A OA 1200300012A OA 1200300012 A OA1200300012 A OA 1200300012A OA 12340 A OA12340 A OA 12340A
Authority
OA
OAPI
Prior art keywords
heparin
activity
benzyl ester
sodium
salt
Prior art date
Application number
OA1200300012A
Other languages
English (en)
French (fr)
Inventor
Jacques Diaz
Christelle Pecquet
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA12340(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of OA12340A publication Critical patent/OA12340A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
OA1200300012A 2000-07-21 2001-07-18 Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. OA12340A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
OA12340A true OA12340A (fr) 2006-05-15

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300012A OA12340A (fr) 2000-07-21 2001-07-18 Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant.

Country Status (36)

Country Link
EP (1) EP1307491B2 (de)
JP (1) JP5279160B2 (de)
KR (1) KR100853585B1 (de)
CN (1) CN1230449C (de)
AP (1) AP1703A (de)
AR (1) AR029865A1 (de)
AT (1) ATE470679T1 (de)
AU (2) AU2001277602B2 (de)
BR (1) BR0112612B1 (de)
CA (1) CA2416673C (de)
CL (1) CL2004001154A1 (de)
CY (1) CY1110774T1 (de)
DE (1) DE60142340D1 (de)
DK (1) DK1307491T3 (de)
DZ (1) DZ3411A1 (de)
EA (1) EA005995B1 (de)
EC (1) ECSP034442A (de)
ES (1) ES2347134T5 (de)
FR (1) FR2811992B1 (de)
HK (1) HK1059273A1 (de)
HR (1) HRP20030019A2 (de)
HU (1) HUP0300755A3 (de)
IL (2) IL153922A0 (de)
MA (1) MA26928A1 (de)
MX (1) MXPA03000579A (de)
NO (1) NO20030296D0 (de)
NZ (1) NZ524028A (de)
OA (1) OA12340A (de)
PL (1) PL202471B1 (de)
PT (1) PT1307491E (de)
SI (1) SI1307491T1 (de)
TW (1) TWI307278B (de)
UA (1) UA74836C2 (de)
WO (1) WO2002008295A1 (de)
YU (1) YU2903A (de)
ZA (1) ZA200300898B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1375524B1 (de) * 2002-06-20 2007-03-07 CHEMI S.p.A. Verfahren zur Herstellung von Heparinestern
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
EP2019843A2 (de) * 2006-05-25 2009-02-04 Momenta Pharmaceuticals, Inc. Heparin-zusammensetzung mit geringem molekulargewicht und anwendungen davon
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399591A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399590A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399592A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399593A1 (de) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
CN103209997B (zh) * 2010-09-14 2016-03-16 国立大学法人宫崎大学 高纯度肝素及其制备方法
EP2446891A1 (de) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin für Verwendung als eine antithrombotische Behandlung in den großen Bauchoperation mit verbesserter Sicherheit in Bezug auf klinisch relevante Blutungen und starken Blutungen
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2548561A1 (de) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin zur Verbesserung der Überlebenschancen von Patienten mit örtlich fortgeschrittenem Krebs
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
ES2161615B1 (es) 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物

Also Published As

Publication number Publication date
NO20030296L (no) 2003-01-20
BR0112612B1 (pt) 2011-07-12
PT1307491E (pt) 2010-09-10
PL202471B1 (pl) 2009-06-30
CA2416673A1 (fr) 2002-01-31
ES2347134T3 (es) 2010-10-26
EP1307491A1 (de) 2003-05-07
ECSP034442A (es) 2003-03-10
AP1703A (en) 2007-02-26
JP2004504451A (ja) 2004-02-12
IL153922A (en) 2010-05-17
PL365561A1 (en) 2005-01-10
KR100853585B1 (ko) 2008-08-21
EA200300178A1 (ru) 2003-06-26
AU2001277602B2 (en) 2007-07-19
MA26928A1 (fr) 2004-12-20
ATE470679T1 (de) 2010-06-15
AP2003002744A0 (en) 2003-03-31
BR0112612A (pt) 2003-07-29
HUP0300755A2 (hu) 2003-12-29
YU2903A (sh) 2006-03-03
NO20030296D0 (no) 2003-01-20
SI1307491T1 (sl) 2010-10-29
JP5279160B2 (ja) 2013-09-04
HRP20030019A2 (en) 2005-10-31
EP1307491B1 (de) 2010-06-09
NZ524028A (en) 2004-12-24
FR2811992A1 (fr) 2002-01-25
CN1230449C (zh) 2005-12-07
CY1110774T1 (el) 2015-06-10
DZ3411A1 (fr) 2002-01-31
ZA200300898B (en) 2004-04-30
AU7760201A (en) 2002-02-05
EA005995B1 (ru) 2005-08-25
WO2002008295A1 (fr) 2002-01-31
CN1447820A (zh) 2003-10-08
HK1059273A1 (en) 2004-06-25
HUP0300755A3 (en) 2004-03-01
KR20030040364A (ko) 2003-05-22
CA2416673C (fr) 2011-06-14
UA74836C2 (en) 2006-02-15
EP1307491B2 (de) 2014-05-07
FR2811992B1 (fr) 2003-07-04
DK1307491T3 (da) 2010-10-11
TWI307278B (en) 2009-03-11
DE60142340D1 (de) 2010-07-22
AR029865A1 (es) 2003-07-16
CL2004001154A1 (es) 2005-05-27
IL153922A0 (en) 2003-07-31
MXPA03000579A (es) 2003-06-06
ES2347134T5 (es) 2014-06-24

Similar Documents

Publication Publication Date Title
CA2416673C (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CA2501546C (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP0287477B1 (de) Heparine mit niedrigem Molekulargewicht und regelmässiger Struktur, ihre Herstellung und biologische Verwendungen
US7812007B2 (en) Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2684385A1 (fr) Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP1651677B1 (de) Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten
EP0116251B1 (de) Verfahren zum Depolymerisieren und Sulfatieren von Polysacchariden
EP0138632A2 (de) Komplexe, welche Oligosaccharide enthalten, ihre Herstellung und ihre biologische und biochemische Verwendung
FR2935387A1 (fr) Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
NZ537411A (en) Heparin-derived polysaccharide mixtures and preparation method
FR2572080A1 (fr) Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
WO2012042123A1 (fr) Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree